SlideShare ist ein Scribd-Unternehmen logo
1 von 28
Annual Epidemiological Report for 2017
Sexually Transmitted Diseases
- chlamydia
- gonorrhoea
- lymphogranuloma venereum
- (congenital) syphilis
1
Chlamydia
• For 2017, 26 EU/EEA Member States reported 409 646
cases of chlamydia infection.
• The crude notification rate was 146 cases per 100 000
population.
• Notification rates of chlamydia infection varied considerably
across Europe, with the highest country-specific rates more
than 5 000 times higher than the lowest rates. This is
believed to be mainly a reflection of the differences in
chlamydia testing, case finding and reporting rather than
indicative of actual differences in chlamydia prevalence.
• Notification rates continue to be highest among young adult
women and heterosexuals.
• The overall trend appears stable over recent years, but
there are variations at country level.
Chlamydia male-to-female ratio,
25 EU/EEA countries, 2017
Chlamydia cases per 100 000 population,
by age group and gender, EU/EEA, 2017
Source: Country reports from Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, Hungary, Iceland, Ireland, Latvia,
Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Chlamydia infections by transmission category
and gender (n=59 991), EU/EEA, 2017
Note: EU/EEA countries with ≥60% completeness in transmission category
Data from Hungary, Italy, Latvia, Lithuania, Malta, the Netherlands, Portugal, Romania, Slovakia, Slovenia and
Sweden.
Confirmed chlamydia cases per 100 000
population by year, EU/EEA countries reporting
consistently, 2008−2017
Source: Country reports from Cyprus, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, Norway,
Poland, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
Lymphogranuloma venereum
• Lymphogranuloma venereum (LGV) is a systemic STI
caused by Chlamydia trachomatis serovars L1, L2, or L3.
• In 2017, 1 989 cases of LGV were reported in 24 countries.
• Four countries (France, the Netherlands, Spain and the
United Kingdom) accounted for 86% of all notified cases.
• Almost all cases in 2017 were reported among men who
have sex with men; among the cases with known HIV
status, 64% were HIV-positive.
• The number of reported cases decreased compared to 2016.
This was the first reduction in the number of reported cases
since 2009.
Age distribution of confirmed LGV cases,
EU/EEA, 2017
Source: Country reports from Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Hungary,
Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal,
Slovenia, Sweden and the United Kingdom.
Confirmed LGV cases among the five EU/EEA
Member States reporting the largest number of
cases in 2017, 2007–2017
Gonorrhoea
• A total of 89 239 cases of gonococcal infection were
reported by 27 EU/EEA Member States for 2017.
• The overall crude notification rate was 22.2 cases per
100 000 population.
• Rates of reported gonococcal infection vary considerably
across Europe, with higher rates reported in northern
Europe.
• Men who have sex with men (MSM) accounted for almost
half of the reported cases (47%) in 2017.
• The overall notification rate increased in 2017 following the
slight reduction seen in 2016.
Rate of confirmed gonorrhoea cases per 100 000
population by country, EU/EEA, 2017
Gonorrhoea male-to-female ratio
in 25 EU/EEA countries, 2017
Rate of confirmed gonorrhoea cases per 100 000
population, by age and gender, EU/EEA, 2017
Source: Country reports from Cyprus, Croatia, the Czech Republic, Denmark, Estonia, Finland, Hungary, Iceland, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
Percentage of gonorrhoea infections by
transmission category and gender (n=68 436),
EU/EEA, 2017
Source: Country reports from the Czech Republic, Denmark, Finland, Hungary, Iceland, Ireland, Latvia, Lithuania, Malta, the
Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
Rate of confirmed gonorrhoea cases per 100 000 population
by year, EU/EEA countries reporting consistently,
2008−2017
Source: Country reports from Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Iceland, Ireland, Italy, Latvia,
Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Number of confirmed gonorrhoea cases by gender,
transmission category and year, EU/EEA countries reporting
consistently, EU/EEA, 2008−2017
Source: Country reports from Cyprus, the Czech Republic, Denmark, France, Latvia, Lithuania, Malta, the Netherlands, Norway,
Romania, Slovenia, Sweden and the United Kingdom.
Syphilis
• In 2017, 33 189 confirmed syphilis cases were reported in
28 EU/EEA Member States; the notification rate was 7.1
cases per 100 000 population.
• Reported syphilis rates were nine times higher in men than
in women and peaked among 25–34-year-old men (28 cases
per 100 000 population).
• Two-thirds (67%) of the syphilis cases with information on
transmission category were reported in men who have sex
with men (MSM).
• The trend in syphilis rates has been on the rise since 2011,
particularly among men, mainly due to an increase in the
number of cases among MSM.
• The slight increase of syphilis rates among women that
started in 2016 continued in 2017.
Rate of confirmed syphilis cases per 100 000
population by country, EU/EEA, 2017
Syphilis male-to-female ratio
in 27 EU/EEA countries, 2017
Rate of confirmed syphilis cases per 100 000
population, by age and gender, EU/EEA, 2017
Source: Country reports from Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Iceland, Ireland,
Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
Percentage of syphilis infections by transmission
category and gender (n=22 745), EU/EEA, 2017
Data from countries reporting transmission category for more than 60% of cases: the Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Latvia, Malta, the Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden and the United
Kingdom..
Distribution of reported syphilis infection
stages, EU/EEA, 2017
Source: Country reports from the Czech Republic, Estonia, France, Hungary, Iceland, Ireland, Latvia, Lithuania, Malta, the
Netherlands, Norway, Romania, Slovakia, Slovenia and the United Kingdom.
Rate of confirmed syphilis cases per 100 000 population
by year, EU/EEA countries reporting consistently,
2008−2017
Source: Country reports from the Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Italy, Latvia,
Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
Number of confirmed syphilis cases by gender,
transmission category and year, EU/EEA countries reporting
consistently, EU/EEA, 2010−2017
Source: Country reports from the Czech Republic, Denmark, Finland, France, Germany, Hungary, Iceland, Ireland, Latvia, Lithuania,
Malta, the Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
Change in number of reported confirmed
cases of gonorrhoea, syphilis and LGV,
EU/EEA, 2013-2017
Source: Countries reporting both in 2013 and 2017. Country reports from Belgium, Bulgaria (not LGV), Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany (syphilis only), Hungary, Iceland, Ireland, Italy
(not LGV), Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania (not LGV),
Slovakia (not LGV), Slovenia, Spain (not LGV), Sweden and the United Kingdom.
Congenital syphilis
• In 2017, 36 congenital syphilis cases were reported in 23
EU/EEA Member States, at a crude rate of 1.1 cases per 100
000 live births.
• The trend for reported congenital syphilis cases has
remained stable in recent years.
• There may be some underreporting: seven countries did not
contribute to the reporting of congenital syphilis and a
further 13 reported no cases for 2017.
• The low rates of congenital syphilis and decreasing rates of
reported syphilis among women suggest that most Member
States have effective programmes for elimination of
congenital syphilis. Better indicator data are needed to
assess the effectiveness of antenatal screening programmes
in all EU/EEA countries.
Number of confirmed congenital syphilis cases
per 100 000 live births; number of countries reporting congenital
syphilis data, by year, 25 EU/EEA countries, 2005–2017
Source: Country reports from Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the
United Kingdom.
Thank you
Follow us on @ECDC_EU or
@ECDC_HIVAIDS

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 
Sexually transmitted infections in Europe, 2013
Sexually transmitted infections in Europe, 2013Sexually transmitted infections in Europe, 2013
Sexually transmitted infections in Europe, 2013
 
Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
 
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 dataSurveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
 
Supporting the global vision of hepatitis B and C elimination - poster for IL...
Supporting the global vision of hepatitis B and C elimination - poster for IL...Supporting the global vision of hepatitis B and C elimination - poster for IL...
Supporting the global vision of hepatitis B and C elimination - poster for IL...
 
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
 
Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
 

Ähnlich wie Annual Epidemiological Report for 2017: Sexually Transmitted Diseases

Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012
Gaby Frankfurt
 

Ähnlich wie Annual Epidemiological Report for 2017: Sexually Transmitted Diseases (19)

Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
 
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
 
Recent epidemiology and outbreaks in Europe
Recent epidemiology and outbreaks in EuropeRecent epidemiology and outbreaks in Europe
Recent epidemiology and outbreaks in Europe
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
 
Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
 
Wtbd 2015 final_eng
Wtbd 2015 final_engWtbd 2015 final_eng
Wtbd 2015 final_eng
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
 
Chancroid - a rare disease in Europe, IUSTI Europe 2016
Chancroid - a rare disease in Europe, IUSTI Europe 2016Chancroid - a rare disease in Europe, IUSTI Europe 2016
Chancroid - a rare disease in Europe, IUSTI Europe 2016
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
World TB Day 2017 - presentation
World TB Day 2017 - presentationWorld TB Day 2017 - presentation
World TB Day 2017 - presentation
 
Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
 
Hepatitis E infections in Hungary, 2002-2014
Hepatitis E infections in Hungary, 2002-2014Hepatitis E infections in Hungary, 2002-2014
Hepatitis E infections in Hungary, 2002-2014
 
Screening Migrants at Europe’s Forefront: Migrant health and infectious disea...
Screening Migrants at Europe’s Forefront: Migrant health and infectious disea...Screening Migrants at Europe’s Forefront: Migrant health and infectious disea...
Screening Migrants at Europe’s Forefront: Migrant health and infectious disea...
 
6249919.ppt
6249919.ppt6249919.ppt
6249919.ppt
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015 World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
 
Hiv in the_uk_2015_report
Hiv in the_uk_2015_reportHiv in the_uk_2015_report
Hiv in the_uk_2015_report
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
 

Mehr von European Centre for Disease Prevention and Control

Mehr von European Centre for Disease Prevention and Control (10)

Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
 
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
 

Kürzlich hochgeladen

POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
Silpa
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
MohamedFarag457087
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
Silpa
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
NazaninKarimi6
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
Scintica Instrumentation
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
Silpa
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
Silpa
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Silpa
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
levieagacer
 

Kürzlich hochgeladen (20)

PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
 
300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
 
Dr. E. Muralinath_ Blood indices_clinical aspects
Dr. E. Muralinath_ Blood indices_clinical  aspectsDr. E. Muralinath_ Blood indices_clinical  aspects
Dr. E. Muralinath_ Blood indices_clinical aspects
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
 
module for grade 9 for distance learning
module for grade 9 for distance learningmodule for grade 9 for distance learning
module for grade 9 for distance learning
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
Cyanide resistant respiration pathway.pptx
Cyanide resistant respiration pathway.pptxCyanide resistant respiration pathway.pptx
Cyanide resistant respiration pathway.pptx
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
 
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxClimate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
 
Clean In Place(CIP).pptx .
Clean In Place(CIP).pptx                 .Clean In Place(CIP).pptx                 .
Clean In Place(CIP).pptx .
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
 

Annual Epidemiological Report for 2017: Sexually Transmitted Diseases

  • 1. Annual Epidemiological Report for 2017 Sexually Transmitted Diseases - chlamydia - gonorrhoea - lymphogranuloma venereum - (congenital) syphilis 1
  • 2. Chlamydia • For 2017, 26 EU/EEA Member States reported 409 646 cases of chlamydia infection. • The crude notification rate was 146 cases per 100 000 population. • Notification rates of chlamydia infection varied considerably across Europe, with the highest country-specific rates more than 5 000 times higher than the lowest rates. This is believed to be mainly a reflection of the differences in chlamydia testing, case finding and reporting rather than indicative of actual differences in chlamydia prevalence. • Notification rates continue to be highest among young adult women and heterosexuals. • The overall trend appears stable over recent years, but there are variations at country level.
  • 3. Chlamydia male-to-female ratio, 25 EU/EEA countries, 2017
  • 4. Chlamydia cases per 100 000 population, by age group and gender, EU/EEA, 2017 Source: Country reports from Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
  • 5. Chlamydia infections by transmission category and gender (n=59 991), EU/EEA, 2017 Note: EU/EEA countries with ≥60% completeness in transmission category Data from Hungary, Italy, Latvia, Lithuania, Malta, the Netherlands, Portugal, Romania, Slovakia, Slovenia and Sweden.
  • 6. Confirmed chlamydia cases per 100 000 population by year, EU/EEA countries reporting consistently, 2008−2017 Source: Country reports from Cyprus, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
  • 7. Lymphogranuloma venereum • Lymphogranuloma venereum (LGV) is a systemic STI caused by Chlamydia trachomatis serovars L1, L2, or L3. • In 2017, 1 989 cases of LGV were reported in 24 countries. • Four countries (France, the Netherlands, Spain and the United Kingdom) accounted for 86% of all notified cases. • Almost all cases in 2017 were reported among men who have sex with men; among the cases with known HIV status, 64% were HIV-positive. • The number of reported cases decreased compared to 2016. This was the first reduction in the number of reported cases since 2009.
  • 8. Age distribution of confirmed LGV cases, EU/EEA, 2017 Source: Country reports from Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Slovenia, Sweden and the United Kingdom.
  • 9. Confirmed LGV cases among the five EU/EEA Member States reporting the largest number of cases in 2017, 2007–2017
  • 10. Gonorrhoea • A total of 89 239 cases of gonococcal infection were reported by 27 EU/EEA Member States for 2017. • The overall crude notification rate was 22.2 cases per 100 000 population. • Rates of reported gonococcal infection vary considerably across Europe, with higher rates reported in northern Europe. • Men who have sex with men (MSM) accounted for almost half of the reported cases (47%) in 2017. • The overall notification rate increased in 2017 following the slight reduction seen in 2016.
  • 11. Rate of confirmed gonorrhoea cases per 100 000 population by country, EU/EEA, 2017
  • 12. Gonorrhoea male-to-female ratio in 25 EU/EEA countries, 2017
  • 13. Rate of confirmed gonorrhoea cases per 100 000 population, by age and gender, EU/EEA, 2017 Source: Country reports from Cyprus, Croatia, the Czech Republic, Denmark, Estonia, Finland, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
  • 14. Percentage of gonorrhoea infections by transmission category and gender (n=68 436), EU/EEA, 2017 Source: Country reports from the Czech Republic, Denmark, Finland, Hungary, Iceland, Ireland, Latvia, Lithuania, Malta, the Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
  • 15. Rate of confirmed gonorrhoea cases per 100 000 population by year, EU/EEA countries reporting consistently, 2008−2017 Source: Country reports from Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
  • 16. Number of confirmed gonorrhoea cases by gender, transmission category and year, EU/EEA countries reporting consistently, EU/EEA, 2008−2017 Source: Country reports from Cyprus, the Czech Republic, Denmark, France, Latvia, Lithuania, Malta, the Netherlands, Norway, Romania, Slovenia, Sweden and the United Kingdom.
  • 17. Syphilis • In 2017, 33 189 confirmed syphilis cases were reported in 28 EU/EEA Member States; the notification rate was 7.1 cases per 100 000 population. • Reported syphilis rates were nine times higher in men than in women and peaked among 25–34-year-old men (28 cases per 100 000 population). • Two-thirds (67%) of the syphilis cases with information on transmission category were reported in men who have sex with men (MSM). • The trend in syphilis rates has been on the rise since 2011, particularly among men, mainly due to an increase in the number of cases among MSM. • The slight increase of syphilis rates among women that started in 2016 continued in 2017.
  • 18. Rate of confirmed syphilis cases per 100 000 population by country, EU/EEA, 2017
  • 19. Syphilis male-to-female ratio in 27 EU/EEA countries, 2017
  • 20. Rate of confirmed syphilis cases per 100 000 population, by age and gender, EU/EEA, 2017 Source: Country reports from Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
  • 21. Percentage of syphilis infections by transmission category and gender (n=22 745), EU/EEA, 2017 Data from countries reporting transmission category for more than 60% of cases: the Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Latvia, Malta, the Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden and the United Kingdom..
  • 22. Distribution of reported syphilis infection stages, EU/EEA, 2017 Source: Country reports from the Czech Republic, Estonia, France, Hungary, Iceland, Ireland, Latvia, Lithuania, Malta, the Netherlands, Norway, Romania, Slovakia, Slovenia and the United Kingdom.
  • 23. Rate of confirmed syphilis cases per 100 000 population by year, EU/EEA countries reporting consistently, 2008−2017 Source: Country reports from the Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
  • 24. Number of confirmed syphilis cases by gender, transmission category and year, EU/EEA countries reporting consistently, EU/EEA, 2010−2017 Source: Country reports from the Czech Republic, Denmark, Finland, France, Germany, Hungary, Iceland, Ireland, Latvia, Lithuania, Malta, the Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and the United Kingdom.
  • 25. Change in number of reported confirmed cases of gonorrhoea, syphilis and LGV, EU/EEA, 2013-2017 Source: Countries reporting both in 2013 and 2017. Country reports from Belgium, Bulgaria (not LGV), Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany (syphilis only), Hungary, Iceland, Ireland, Italy (not LGV), Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania (not LGV), Slovakia (not LGV), Slovenia, Spain (not LGV), Sweden and the United Kingdom.
  • 26. Congenital syphilis • In 2017, 36 congenital syphilis cases were reported in 23 EU/EEA Member States, at a crude rate of 1.1 cases per 100 000 live births. • The trend for reported congenital syphilis cases has remained stable in recent years. • There may be some underreporting: seven countries did not contribute to the reporting of congenital syphilis and a further 13 reported no cases for 2017. • The low rates of congenital syphilis and decreasing rates of reported syphilis among women suggest that most Member States have effective programmes for elimination of congenital syphilis. Better indicator data are needed to assess the effectiveness of antenatal screening programmes in all EU/EEA countries.
  • 27. Number of confirmed congenital syphilis cases per 100 000 live births; number of countries reporting congenital syphilis data, by year, 25 EU/EEA countries, 2005–2017 Source: Country reports from Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
  • 28. Thank you Follow us on @ECDC_EU or @ECDC_HIVAIDS

Hinweis der Redaktion

  1. Note: In 2008, the United Kingdom started including data from a screening programme targeted at 15–24-year-olds in England. This programme offers community-based testing services outside of STI clinics and resulted in a large increase of chlamydia diagnoses from 2008 onwards.